drugset / Trial / NCT00775450
Influenza Vaccine Revaccination in Ambulatory Elderly Subjects
RandomizedParallel-groupOpen-labelPrevention
Summary
This is a multi-center study designed to evaluate the safety and immunogenicity of a Fluzone revaccination in elderly adults aged ≥ 65 years. Primary Objective: To describe the safety profile for all subjects. Secondary Objective: To describe immunogenicity 28 days following revaccination with one of three Fluzone formulations.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-06
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Influenza Virus Vaccine USP Trivalent Types A and B | Vaccine | 0.1 ml | Intramuscular |
| Comparator | Influenza Virus Vaccine USP Trivalent Types A and B | Vaccine | 0.5 ml | Intramuscular |